CD45 depleted CTC-enriched fractions expressing CXCR4, and the alpha-chemokine receptor specific for stromal-derived-factor-1, isolated from the PB of prostate cancer patients through the CellSearch® platform, documented poor prognosis in patients treated by radiotherapy [101]. This evidence concerns the gene CXCR4 and prostate carcinoma.